Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope

Eli Lilly Shares Approach Record High While Retatrutide Legal Action Secures New Obesity Hope

Shares of Eli Lilly and Company rose 0.5% to $1,226.64 early on Thursday, after six lawsuits were filed over alleged illegal sales of retatrutide, the company's experimental drug for obesity. The stock was trading 1.8% below its peak of $1,249.45.
Nvidia Stock (NVDA) Gains 3% in Premarket Amid Analyst Target $563 Below Current Level—Potential Caution Flag

Nvidia Stock (NVDA) Gains 3% in Premarket Amid Analyst Target $563 Below Current Level—Potential Caution Flag

NVIDIA rose 3.03% on Wednesday, driven by a recovery in AI infrastructure stocks. However, broader investor focus remains on Wall Street's outlook. Analyst price targets now stretch from $180 to $743, with consensus positioned at approximately $314.

Latest

Stock Market Today: Live Updates 14.08.2026

Stock Market Today: Live Updates 14.08.2026

LIVEMarkets rolling coverageStarted: August 14, 2026, 4:00 AM EDTUpdated: August 14, 2026, 4:49 AM EDT Accelerant Jumps 44% After Thoma Bravo's $20.25 Cash Bid; 4% Spread Persists August 14, 2026, 4:49 AM EDT. Shares in Accelerant Holdings (NYSE:ARX) soared 44% as Thoma Bravo made a $20.25 per share all-cash proposal, offering a 49% premium and implying a valuation close to $4.4 billion. The deal’s arbitrage spread held at 4% with premarket trading at $19.47 on August 14, 2026. Altamont Capital, holding 82% of voting power, supports the buyout, which the board committee backed unanimously and aims to close in H1